The Plasma Protein Therapeutics Association (PPTA) and its members are presenting a series of webinars for consumers of plasma protein therapies and their families on the impact of federal health reform. The first webinar will be held on Thursday, August 19, 2-3 PM (Eastern).

 

Many of us have read information on health reform, but with such sweeping change most of the information available has not focused on the threats and benefits of the new law on those with rare diseases and conditions that require access to life-saving therapies, such as blood clotting factor, immune globulins and alpha-1 proteinase inhibitor.

 

This webinar series, presented by experts on the law and how it will be carried out, will consider such issues as: medical loss ratios, state exchanges and individual mandates--what do these terms mean? And, what will they mean for you, your physician and your treatment?

 

The first webinar, held on Thursday, August 19 at 2PM, will examine high-risk pools for individuals with pre-existing conditions, such as users of plasma protein therapies. It will cover which insurance plans must comply with the health reform law and what that may mean to you. You will have the opportunity to interact with presenters and ask questions about how the law will affect you.

 

To register, e-mail Bill Speir, Assistant Director, State Affairs at PPTA: bspeir@pptaglobal.org. The program is limited to the first 125 participants, so sign up today if you are interested. Registrants will receive the information regarding the Web site link and toll-free number to call in order to participate in this webinar.